BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34755283)

  • 21. Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.
    Mosaferi T; Tsai K; Sovich S; Wilhalme H; Kathuria-Prakash N; Praw SS; Drakaki A; Angell TE; Lechner MG
    Thyroid; 2022 May; 32(5):496-504. PubMed ID: 35199588
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
    Tariq A; Wert Y; Cheriyath P; Joshi R
    South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
    Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
    Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compared with classic Hashimoto's thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of L-thyroxine to correct hypothyroidism.
    Croce L; De Martinis L; Pinto S; Coperchini F; Dito G; Bendotti G; Pasquali D; Cappelli C; Latrofa F; Magri F; Chiovato L; Rotondi M
    J Endocrinol Invest; 2020 Nov; 43(11):1631-1636. PubMed ID: 32319047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study.
    Bjerkreim BA; Hammerstad SS; Gulseth HL; Berg TJ; Omdal LJ; Lee-Ødegård S; Eriksen EF
    Front Endocrinol (Lausanne); 2022; 13():816566. PubMed ID: 35273566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.
    Peterson SJ; Cappola AR; Castro MR; Dayan CM; Farwell AP; Hennessey JV; Kopp PA; Ross DS; Samuels MH; Sawka AM; Taylor PN; Jonklaas J; Bianco AC
    Thyroid; 2018 Jun; 28(6):707-721. PubMed ID: 29620972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EMPATHY: A New Tool for Identifying the Most Suitable Thyroxine Formulation in Hypothyroid Patients.
    Bellastella G; Caputo M; Maiorino MI; Longo M; Scappaticcio L; Giugliano D; Esposito K
    Thyroid; 2019 Jul; 29(7):928-933. PubMed ID: 30963820
    [No Abstract]   [Full Text] [Related]  

  • 28. Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
    Gottwald-Hostalek U; Kahaly GJ
    Curr Med Res Opin; 2021 Dec; 37(12):2099-2106. PubMed ID: 34553643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?
    Casula S; Ettleson MD; Bianco AC
    Endocr Pract; 2023 Jul; 29(7):581-588. PubMed ID: 37419565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
    Solter D; Solter M
    Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of levothyroxine for euthyroid, thyroid antibody positive women with infertility: Analyses of aggregate data from a survey of European thyroid specialists (Treatment of Hypothyroidism in Europe by Specialists: An International Survey).
    Negro R; Žarković M; Attanasio R; Hegedüs L; Nagy EV; Papini E; Akarsu E; Alevizaki M; Ayvaz G; Bednarczuk T; Beleslin BN; Berta E; Bodor M; Borissova AM; Boyanov M; Buffet C; Burlacu MC; Ćirić J; Cohen CA; Díez JJ; Dobnig H; Fadeyev V; Field BCT; Fliers E; Führer D; Galofré JC; Hakala T; Jan J; Kopp P; Krebs M; Kršek M; Kužma M; Leenhardt L; Luchytskiy V; Puga FM; McGowan A; Melo M; Metso S; Moran C; Morgunova T; Niculescu DA; Perić B; Planck T; Poiana C; Robenshtok E; Rosselet PO; Ruchala M; Riis KR; Shepelkevich A; Tronko M; Unuane D; Vardarli I; Visser E; Vryonidou A; Younes YR; Perros P
    Clin Endocrinol (Oxf); 2024 Jun; ():. PubMed ID: 38856700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.
    Jonklaas J; Tefera E; Shara N
    Thyroid; 2018 Nov; 28(11):1416-1424. PubMed ID: 30289349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liothyronine use in primary hypothyroidism - current concepts.
    Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
    Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
    Premawardhana LD; Taylor PN; Okosieme OE; Adlan MA; Obuobie EK; Dayan CM
    Front Endocrinol (Lausanne); 2023; 14():1282608. PubMed ID: 38034018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 36. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis.
    Tortora A; La Sala D; Vitale M
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH; Eng PH; Ho SC; Fok AC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.
    Hennessey JV; Espaillat R
    Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Takahashi S; Ito M; Masaki Y; Hada M; Minakata M; Kohsaka K; Nakamura T; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
    Endocr J; 2021 Mar; 68(3):353-360. PubMed ID: 33239477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.